High Times Marks 10 Years of Khalifa Kush as Celebrity Brand Endures
A High Times retrospective says Wiz Khalifa's strain-led brand outlasted the celebrity weed boom, and the cultivar-first model is the reason.

High-quality close-up image of dried cannabis buds in a clear glass container, showcasing texture and detail.
A decade in, the strain is still the headline
High Times Magazine published a retrospective on Oct. 31, 2026, titled "Khalifa Kush at 10," framing Wiz Khalifa's brand as a survivor of the celebrity weed boom. The piece positions the brand as an outlier among famous-name cannabis lines.
Here's the caveat up front. The High Times headline is the only part of that story CannIntel has confirmed for this report. We haven't independently verified sales figures, licensing partners or market footprints, so we aren't printing any.
What we can do is explain why the framing holds up. It comes down to what the brand sells.
Why a cultivar outlasts a logo
Khalifa Kush leads with a strain name, and strain names carry meaning with consumers that a celebrity's face doesn't. Say "Kush" to a budtender and the shopper's nose is already half-sold: pine, fuel, damp earth, the forest-floor opener that defined West Coast flower for a generation.
That's the real trick. The name borrows equity from the OG Kush family tree, a lineage so broad that every dispensary shelf has a cousin of it. Lineage claims on branded cuts vary by source, and we aren't asserting a parentage here. The marketing logic doesn't depend on it.
A celebrity vape pen is a license deal. A recognizable Kush is a reason to buy again. One of those survives a shakeout.
What thinned the celebrity herd
Most celebrity cannabis lines are licensing arrangements, and licensing arrangements are fragile when the operator behind them struggles. That's CannIntel's read, not a finding from the High Times piece.
The economics are punishing. Plant-touching operators still can't deduct ordinary business expenses under IRC Section 280E, which squeezes the margins that a celebrity royalty has to come out of. Add price compression in mature state markets and a shopper who now reads the THCA percentage and the harvest date before the name on the jar.
Fame buys a first purchase. It doesn't buy a fifth.
Why Wiz fits the product
Wiz Khalifa's public identity has been tied to smoking since his 2011 album Rolling Papers, which gives a strain brand an authenticity most celebrity partners can't manufacture. The Pittsburgh native didn't arrive at cannabis through a pivot or a press-release partnership.
That matters in a category where consumers sniff out borrowed credibility quickly, and a rapper who has talked about cannabis for his entire career is selling continuity, not a campaign.
It also helps that the product is a flower-first, smoke-first idea. Nothing about it requires a reinvention every eighteen months.
The model operators should steal
The durable celebrity play is a short list: a named cultivar, a personality with a decade-plus public record, and a product category that doesn't chase trends. Brands that fell short tended to miss at least one.
- Name the cultivar, not just the person.
- Pick a partner whose cannabis history predates the deal.
- Keep the core product boring and consistent.
Snoop Dogg and Willie Nelson are the obvious comparisons, since both attached long-running public identities to cannabis, and both are covered in our topic hub on celebrity cannabis brands. Khalifa Kush now joins that short list of names with a calendar-year milestone.
What the retrospective leaves open
A ten-year anniversary proves longevity, not profitability, and the High Times headline can't tell investors which one they're looking at. That gap is the story behind the story.
Brand longevity in cannabis is easy to celebrate and hard to audit. Private licensing terms rarely surface, and state markets from California to Ohio report sales by category, not by celebrity label. A brand can be everywhere on shelves and thin on margin. The reverse is also possible.
So the useful question isn't whether Khalifa Kush is famous. It's whether the model scales without eroding the thing that made it work, and that's a question only the operators can answer.
The next signal to watch is whether other celebrity lines respond to this anniversary by shifting from logo-first to cultivar-first launches in 2027, which would show the industry is learning the lesson rather than just reading about it.
Frequently asked questions
What is Khalifa Kush?
Khalifa Kush is the cannabis brand and strain name associated with rapper Wiz Khalifa. High Times Magazine published a retrospective titled "Khalifa Kush at 10" on Oct. 31, 2026, marking a decade of the brand.
Why did High Times say Khalifa Kush outlasted the celebrity weed boom?
According to the headline of its Oct. 31, 2026 piece, High Times argues the brand outlasted the boom in celebrity-branded cannabis. CannIntel hasn't independently verified the supporting details, such as sales or licensing terms.
Does CannIntel know the genetics of Khalifa Kush?
Not from this signal. Lineage claims for branded cuts vary by source, and the High Times headline doesn't supply parentage, so we aren't asserting one. Check the licensed producer's lab results for any specific batch.
Why do celebrity cannabis brands fail?
CannIntel's read is that many are thin licensing deals exposed to operator problems, 280E tax pressure and price compression. Shoppers also increasingly buy on potency, harvest date and quality rather than the name on the jar.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Culture

RealClearEducation publishes 'Why So Many Students Are Stoned'
A new RealClearEducation piece puts student cannabis use back on the agenda, and the questions it raises turn on potency, product format and access.

West Hollywood Launches 'West Hollyweed Stories' for 30 Years of Medical Cannabis
The city is marking three decades since California voters approved Proposition 215 with a storytelling project, according to a WEHO Times report.

Haverhill Dispensaries Plan Joint Cannabis Rights March
WBZ NewsRadio 1030 reported that licensed Haverhill retailers are organizing together for a march, with date, route and demands not yet public.
More from the newsroom

Review Finds CBD May Shield Brain From Meth Injury, Trials Absent
A review reported Oct. 31 says cannabidiol may protect against methamphetamine-related brain damage through several pathways, but no human trial data is cited in the report.

University of Florida Study Finds 81% Cut Opioids With Medical Cannabis
A University of Florida study reports 94% of chronic pain patients saw relief and 81% reduced or stopped opioids, though key methodology details remain unreported.

Mount Olive Cannabis License Renewed Over Council Opposition
A New Jersey Hills Media Group report says a Mount Olive cannabis license was renewed despite council opposition, a fresh test of local leverage in the state's market.